Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 1 July, 2021
pertuzumab
By
vgreene
, 1 July, 2021
margetuximab
By
vgreene
, 1 July, 2021
lapatinib
By
vgreene
, 1 July, 2021
fam trastuzumab deruxtecan
By
vgreene
, 1 July, 2021
ado trastuzumab emtansine
By
vgreene
, 1 July, 2021
View epocrates drug info
By
vgreene
, 30 June, 2021
Monitoring During Tx (option 2):
By
vgreene
, 30 June, 2021
Monitoring During Tx option 2
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx (Option 2)
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx Option 2
Pagination
First page
Previous page
…
Page
1031
Page
1032
Page
1033
Page
1034
Current page
1035
Page
1036
Page
1037
Page
1038
Page
1039
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
